EMEA (Europe, Middle East and Africa) Biologics and Biosimilars Market Report 2017

Published Date : 2017-05-11

Published By : Qy Research Groups

Category : Pharma & Healthcare

No. of Pages : 120

In this report, the EMEA Biologics and Biosimilars market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Biologics and Biosimilars for these regions, from 2012 to 2022 (forecast)
Europe: Germany, France, UK, Russia, Italy and Benelux;
Middle East: Saudi Arabia, Israel, UAE and Iran;
Africa: South Africa, Nigeria, Egypt and Algeria.

EMEA Biologics and Biosimilars market competition by top manufacturers/players, with Biologics and Biosimilars sales volume (K MT), price (USD/MT), revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Roche
Amgen
AbbVie
Sanofi
Johnson & Johnson
Novo Nordisk
Novartis
Merck
Lilly
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma
Sandoz
Teva
Hospira
Mylan
3sbio
Changchun High Tech
CP Guojian Pharmacy
Biotech Pharma
Gelgen Biopharma

On the basis of product, this report displays the sales volume (K MT), revenue (Million USD), product price (USD/MT), market share and growth rate of each type, primarily split into
Antibiotic
Enzyme
Hormone
Non-Patented Biological Reagents
Other

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume (K MT), market share and growth rate of Biologics and Biosimilars for each application, including
Tumor
Diabetes
Cardiovascular
Hemophilia
Other

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

EMEA (Europe, Middle East and Africa) Biologics and Biosimilars Market Report 2017
1 Biologics and Biosimilars Overview
1.1 Product Overview and Scope of Biologics and Biosimilars
1.2 Classification of Biologics and Biosimilars
1.2.1 EMEA Biologics and Biosimilars Market Size (Sales) Comparison by Type (2012-2022)
1.2.2 EMEA Biologics and Biosimilars Market Size (Sales) Market Share by Type (Product Category) in 2016
1.2.3 Antibiotic
1.2.4 Enzyme
1.2.5 Hormone
1.2.6 Non-Patented Biological Reagents
1.2.7 Other
1.3 EMEA Biologics and Biosimilars Market by Application/End Users
1.3.1 EMEA Biologics and Biosimilars Sales (Volume) and Market Share Comparison by Application (2012-2022
1.3.2 Tumor
1.3.3 Diabetes
1.3.4 Cardiovascular
1.3.5 Hemophilia
1.3.6 Other
1.4 EMEA Biologics and Biosimilars Market by Region
1.4.1 EMEA Biologics and Biosimilars Market Size (Value) Comparison by Region (2012-2022)
1.4.2 Europe Status and Prospect (2012-2022)
1.4.3 Middle East Status and Prospect (2012-2022)
1.4.4 Africa Status and Prospect (2012-2022)
1.5 EMEA Market Size (Value and Volume) of Biologics and Biosimilars (2012-2022)
1.5.1 EMEA Biologics and Biosimilars Sales and Growth Rate (2012-2022)
1.5.2 EMEA Biologics and Biosimilars Revenue and Growth Rate (2012-2022)

2 EMEA Biologics and Biosimilars Competition by Manufacturers/Players/Suppliers, Region, Type and Application
2.1 EMEA Biologics and Biosimilars Market Competition by Players/Manufacturers
2.1.1 EMEA Biologics and Biosimilars Sales Volume and Market Share of Major Players (2012-2017)
2.1.2 EMEA Biologics and Biosimilars Revenue and Share by Players (2012-2017)
2.1.3 EMEA Biologics and Biosimilars Sale Price by Players (2012-2017)
2.2 EMEA Biologics and Biosimilars (Volume and Value) by Type/Product Category
2.2.1 EMEA Biologics and Biosimilars Sales and Market Share by Type (2012-2017)
2.2.2 EMEA Biologics and Biosimilars Revenue and Market Share by Type (2012-2017)
2.2.3 EMEA Biologics and Biosimilars Sale Price by Type (2012-2017)
2.3 EMEA Biologics and Biosimilars (Volume) by Application
2.4 EMEA Biologics and Biosimilars (Volume and Value) by Region
2.4.1 EMEA Biologics and Biosimilars Sales and Market Share by Region (2012-2017)
2.4.2 EMEA Biologics and Biosimilars Revenue and Market Share by Region (2012-2017)
2.4.3 EMEA Biologics and Biosimilars Sales Price by Region (2012-2017)

3 Europe Biologics and Biosimilars (Volume, Value and Sales Price), by Players, Countries, Type and Application
3.1 Europe Biologics and Biosimilars Sales and Value (2012-2017)
3.1.1 Europe Biologics and Biosimilars Sales Volume and Growth Rate (2012-2017)
3.1.2 Europe Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
3.2 Europe Biologics and Biosimilars Sales and Market Share by Type
3.3 Europe Biologics and Biosimilars Sales and Market Share by Application
3.4 Europe Biologics and Biosimilars Sales Volume and Value (Revenue) by Countries
3.4.1 Europe Biologics and Biosimilars Sales Volume by Countries (2012-2017)
3.4.2 Europe Biologics and Biosimilars Revenue by Countries (2012-2017)
3.4.3 Germany Biologics and Biosimilars Sales and Growth Rate (2012-2017)
3.4.4 France Biologics and Biosimilars Sales and Growth Rate (2012-2017)
3.4.5 UK Biologics and Biosimilars Sales and Growth Rate (2012-2017)
3.4.6 Russia Biologics and Biosimilars Sales and Growth Rate (2012-2017)
3.4.7 Italy Biologics and Biosimilars Sales and Growth Rate (2012-2017)
3.4.8 Benelux Biologics and Biosimilars Sales and Growth Rate (2012-2017)

4 Middle East Biologics and Biosimilars (Volume, Value and Sales Price), by Region, Type and Application
4.1 Middle East Biologics and Biosimilars Sales and Value (2012-2017)
4.1.1 Middle East Biologics and Biosimilars Sales Volume and Growth Rate (2012-2017)
4.1.2 Middle East Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
4.2 Middle East Biologics and Biosimilars Sales and Market Share by Type
4.3 Middle East Biologics and Biosimilars Sales and Market Share by Application
4.4 Middle East Biologics and Biosimilars Sales Volume and Value (Revenue) by Countries
4.4.1 Middle East Biologics and Biosimilars Sales Volume by Countries (2012-2017)
4.4.2 Middle East Biologics and Biosimilars Revenue by Countries (2012-2017)
4.4.3 Saudi Arabia Biologics and Biosimilars Sales and Growth Rate (2012-2017)
4.4.4 Israel Biologics and Biosimilars Sales and Growth Rate (2012-2017)
4.4.5 UAE Biologics and Biosimilars Sales and Growth Rate (2012-2017)
4.4.6 Iran Biologics and Biosimilars Sales and Growth Rate (2012-2017)

5 Africa Biologics and Biosimilars (Volume, Value and Sales Price) by Players, Countries, Type and Application
5.1 Africa Biologics and Biosimilars Sales and Value (2012-2017)
5.1.1 Africa Biologics and Biosimilars Sales Volume and Growth Rate (2012-2017)
5.1.2 Africa Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
5.2 Africa Biologics and Biosimilars Sales and Market Share by Type
5.3 Africa Biologics and Biosimilars Sales and Market Share by Application
5.4 Africa Biologics and Biosimilars Sales Volume and Value (Revenue) by Countries
5.4.1 Africa Biologics and Biosimilars Sales Volume by Countries (2012-2017)
5.4.2 Africa Biologics and Biosimilars Revenue by Countries (2012-2017)
5.4.3 South Africa Biologics and Biosimilars Sales and Growth Rate (2012-2017)
5.4.4 Nigeria Biologics and Biosimilars Sales and Growth Rate (2012-2017)
5.4.5 Egypt Biologics and Biosimilars Sales and Growth Rate (2012-2017)
5.4.6 Algeria Biologics and Biosimilars Sales and Growth Rate (2012-2017)

6 EMEA Biologics and Biosimilars Manufacturers/Players Profiles and Sales Data
6.1 Pfizer
6.1.1 Company Basic Information, Manufacturing Base and Competitors
6.1.2 Biologics and Biosimilars Product Type, Application and Specification
6.1.2.1 Product A
6.1.2.2 Product B
6.1.3 Pfizer Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.1.4 Main Business/Business Overview
6.2 Roche
6.2.1 Company Basic Information, Manufacturing Base and Competitors
6.2.2 Biologics and Biosimilars Product Type, Application and Specification
6.2.2.1 Product A
6.2.2.2 Product B
6.2.3 Roche Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.2.4 Main Business/Business Overview
6.3 Amgen
6.3.1 Company Basic Information, Manufacturing Base and Competitors
6.3.2 Biologics and Biosimilars Product Type, Application and Specification
6.3.2.1 Product A
6.3.2.2 Product B
6.3.3 Amgen Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.3.4 Main Business/Business Overview
6.4 AbbVie
6.4.1 Company Basic Information, Manufacturing Base and Competitors
6.4.2 Biologics and Biosimilars Product Type, Application and Specification
6.4.2.1 Product A
6.4.2.2 Product B
6.4.3 AbbVie Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.4.4 Main Business/Business Overview
6.5 Sanofi
6.5.1 Company Basic Information, Manufacturing Base and Competitors
6.5.2 Biologics and Biosimilars Product Type, Application and Specification
6.5.2.1 Product A
6.5.2.2 Product B
6.5.3 Sanofi Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.5.4 Main Business/Business Overview
6.6 Johnson & Johnson
6.6.1 Company Basic Information, Manufacturing Base and Competitors
6.6.2 Biologics and Biosimilars Product Type, Application and Specification
6.6.2.1 Product A
6.6.2.2 Product B
6.6.3 Johnson & Johnson Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.6.4 Main Business/Business Overview
6.7 Novo Nordisk
6.7.1 Company Basic Information, Manufacturing Base and Competitors
6.7.2 Biologics and Biosimilars Product Type, Application and Specification
6.7.2.1 Product A
6.7.2.2 Product B
6.7.3 Novo Nordisk Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.7.4 Main Business/Business Overview
6.8 Novartis
6.8.1 Company Basic Information, Manufacturing Base and Competitors
6.8.2 Biologics and Biosimilars Product Type, Application and Specification
6.8.2.1 Product A
6.8.2.2 Product B
6.8.3 Novartis Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.8.4 Main Business/Business Overview
6.9 Merck
6.9.1 Company Basic Information, Manufacturing Base and Competitors
6.9.2 Biologics and Biosimilars Product Type, Application and Specification
6.9.2.1 Product A
6.9.2.2 Product B
6.9.3 Merck Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.9.4 Main Business/Business Overview
6.10 Lilly
6.10.1 Company Basic Information, Manufacturing Base and Competitors
6.10.2 Biologics and Biosimilars Product Type, Application and Specification
6.10.2.1 Product A
6.10.2.2 Product B
6.10.3 Lilly Biologics and Biosimilars Sales, Revenue, Price and Gross Margin (2012-2017)
6.10.4 Main Business/Business Overview
6.11 3sbio
6.12 Changchun High Tech
6.13 CP Guojian Pharmacy
6.14 Biotech Pharma
6.15 Gelgen Biopharma
6.16 Sandoz
6.17 Teva
6.18 Hospira
6.19 Mylan
6.20 3sbio
6.21 Changchun High Tech
6.22 CP Guojian Pharmacy
6.23 Biotech Pharma
6.24 Gelgen Biopharma

7 Biologics and Biosimilars Manufacturing Cost Analysis
7.1 Biologics and Biosimilars Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Price Trend of Key Raw Materials
7.1.3 Key Suppliers of Raw Materials
7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.2.1 Raw Materials
7.2.2 Labor Cost
7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Biologics and Biosimilars

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
8.1 Biologics and Biosimilars Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2016
8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
9.1 Marketing Channel
9.1.1 Direct Marketing
9.1.2 Indirect Marketing
9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
9.2.1 Pricing Strategy
9.2.2 Brand Strategy
9.2.3 Target Client
9.3 Distributors/Traders List

10 Market Effect Factors Analysis
10.1 Technology Progress/Risk
10.1.1 Substitutes Threat
10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 EMEA Biologics and Biosimilars Market Forecast (2017-2022)
11.1 EMEA Biologics and Biosimilars Sales, Revenue and Price Forecast (2017-2022)
11.1.1 EMEA Biologics and Biosimilars Sales and Growth Rate Forecast (2017-2022)
11.1.2 EMEA Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2022)
11.1.3 EMEA Biologics and Biosimilars Price and Trend Forecast (2017-2022)
11.2 EMEA Biologics and Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.3 Europe Biologics and Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.4 Middle Eastt Biologics and Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.5 Africa Biologics and Biosimilars Sales, Revenue and Growth Rate Forecast by Region (2017-2022)
11.6 EMEA Biologics and Biosimilars Sales Forecast by Type (2017-2022)
11.7 EMEA Biologics and Biosimilars Sales Forecast by Application (2017-2022)

12 Research Findings and Conclusion

13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer



List of Tables and Figures

Figure Product Picture of Biologics and Biosimilars
Figure EMEA Biologics and Biosimilars Sales Volume (K MT) by Type (2012-2022)
Figure EMEA Biologics and Biosimilars Sales Volume Market Share by Type (Product Category) in 2016
Figure Antibiotic Product Picture
Figure Enzyme Product Picture
Figure Hormone Product Picture
Figure Non-Patented Biological Reagents Product Picture
Figure Other Product Picture
Figure EMEA Biologics and Biosimilars Sales Volume (K MT) by Application (2012-2022)
Figure EMEA Sales Market Share of Biologics and Biosimilars by Application in 2016
Figure Tumor Examples
Figure Diabetes Examples
Figure Cardiovascular Examples
Figure Hemophilia Examples
Figure Other Examples
Figure EMEA Biologics and Biosimilars Market Size (Million USD) by Region (2012-2022)
Figure Europe Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Europe Biologics and Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure Middle East Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Middle East Biologics and Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure Africa Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure Africa Biologics and Biosimilars Revenue (Million USD) Status and Forecast by Countries
Figure EMEA Biologics and Biosimilars Sales Volume and Growth Rate (2012-2022)
Figure EMEA Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2022)
Figure EMEA Biologics and Biosimilars Market Major Players Product Sales Volume (K MT) (2012-2017)
Table EMEA Biologics and Biosimilars Sales Volume (K MT) of Major Players (2012-2017)
Table EMEA Biologics and Biosimilars Sales Share by Players (2012-2017)
Figure 2016 Biologics and Biosimilars Sales Share by Players
Figure 2017 Biologics and Biosimilars Sales Share by Players
Figure EMEA Biologics and Biosimilars Market Major Players Product Revenue (Million USD) (2012-2017)
Table EMEA Biologics and Biosimilars Revenue (Million USD) by Players (2012-2017)
Table EMEA Biologics and Biosimilars Revenue Share by Players (2012-2017)
Table 2016 EMEA Biologics and Biosimilars Revenue Share by Players
Table 2017 EMEA Biologics and Biosimilars Revenue Share by Players
Table EMEA Biologics and Biosimilars Sale Price (USD/MT) by Players (2012-2017)
Table EMEA Biologics and Biosimilars Sales (K MT) and Market Share by Type (2012-2017)
Table EMEA Biologics and Biosimilars Sales Share by Type (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Type (2012-2017)
Figure EMEA Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Table EMEA Biologics and Biosimilars Revenue (Million USD) and Market Share by Type (2012-2017)
Table EMEA Biologics and Biosimilars Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Biologics and Biosimilars by Type in 2016
Table EMEA Biologics and Biosimilars Sale Price (USD/MT) by Type (2012-2017)
Table EMEA Biologics and Biosimilars Sales (K MT) and Market Share by Application (2012-2017)
Table EMEA Biologics and Biosimilars Sales Share by Application (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Application (2012-2017)
Figure EMEA Biologics and Biosimilars Sales Market Share by Application in 2016
Table EMEA Biologics and Biosimilars Sales (K MT) and Market Share by Region (2012-2017)
Table EMEA Biologics and Biosimilars Sales Share by Region (2012-2017)
Figure Sales Market Share of Biologics and Biosimilars by Region (2012-2017)
Figure EMEA Biologics and Biosimilars Sales Market Share in 2016
Table EMEA Biologics and Biosimilars Revenue (Million USD) and Market Share by Region (2012-2017)
Table EMEA Biologics and Biosimilars Revenue Share by Region (2012-2017)
Figure Revenue Market Share of Biologics and Biosimilars by Region (2012-2017)
Figure EMEA Biologics and Biosimilars Revenue Market Share Regions in 2016
Table EMEA Biologics and Biosimilars Sales Price (USD/MT) by Region (2012-2017)
Figure Europe Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Europe Biologics and Biosimilars Revenue and Growth Rate (2012-2017)
Table Europe Biologics and Biosimilars Sales (K MT) by Type (2012-2017)
Table Europe Biologics and Biosimilars Market Share by Type (2012-2017)
Figure Europe Biologics and Biosimilars Market Share by Type in 2016
Table Europe Biologics and Biosimilars Sales (K MT) by Application (2012-2017)
Table Europe Biologics and Biosimilars Market Share by Application (2012-2017)
Figure Europe Biologics and Biosimilars Market Share by Application in 2016
Table Europe Biologics and Biosimilars Sales (K MT) by Countries (2012-2017)
Table Europe Biologics and Biosimilars Sales Market Share by Countries (2012-2017)
Figure Europe Biologics and Biosimilars Sales Market Share by Countries (2012-2017)
Figure Europe Biologics and Biosimilars Sales Market Share by Countries in 2016
Table Europe Biologics and Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Europe Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Europe Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Europe Biologics and Biosimilars Revenue Market Share by Countries in 2016
Figure Germany Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure France Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure UK Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Russia Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Italy Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Benelux Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Middle East Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Table Middle East Biologics and Biosimilars Sales (K MT) by Type (2012-2017)
Table Middle East Biologics and Biosimilars Market Share by Type (2012-2017)
Figure Middle East Biologics and Biosimilars Market Share by Type (2012-2017)
Table Middle East Biologics and Biosimilars Sales (K MT) by Applications (2012-2017)
Table Middle East Biologics and Biosimilars Market Share by Applications (2012-2017)
Figure Middle East Biologics and Biosimilars Sales Market Share by Application in 2016
Table Middle East Biologics and Biosimilars Sales Volume (K MT) by Countries (2012-2017)
Table Middle East Biologics and Biosimilars Sales Volume Market Share by Countries (2012-2017)
Figure Middle East Biologics and Biosimilars Sales Volume Market Share by Countries in 2016
Table Middle East Biologics and Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Middle East Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Middle East Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Middle East Biologics and Biosimilars Revenue Market Share by Countries in 2016
Figure Saudi Arabia Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Israel Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure UAE Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Iran Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Africa Biologics and Biosimilars Revenue (Million USD) and Growth Rate (2012-2017)
Table Africa Biologics and Biosimilars Sales (K MT) by Type (2012-2017)
Table Africa Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure Africa Biologics and Biosimilars Sales Market Share by Type (2012-2017)
Figure Africa Biologics and Biosimilars Sales Market Share by Type in 2016
Table Africa Biologics and Biosimilars Sales (K MT) by Application (2012-2017)
Table Africa Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Figure Africa Biologics and Biosimilars Sales Market Share by Application (2012-2017)
Table Africa Biologics and Biosimilars Sales Volume (K MT) by Countries (2012-2017)
Table Africa Biologics and Biosimilars Sales Market Share by Countries (2012-2017)
Figure Africa Biologics and Biosimilars Sales Market Share by Countries (2012-2017)
Figure Africa Biologics and Biosimilars Sales Market Share by Countries in 2016
Table Africa Biologics and Biosimilars Revenue (Million USD) by Countries (2012-2017)
Table Africa Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Africa Biologics and Biosimilars Revenue Market Share by Countries (2012-2017)
Figure Africa Biologics and Biosimilars Revenue Market Share by Countries in 2016
Figure South Africa Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Nigeria Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Egypt Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Algeria Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Table Pfizer Biologics and Biosimilars Basic Information List
Table Pfizer Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Pfizer Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Pfizer Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Pfizer Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Roche Biologics and Biosimilars Basic Information List
Table Roche Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Roche Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Roche Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Roche Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Amgen Biologics and Biosimilars Basic Information List
Table Amgen Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Amgen Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Amgen Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Amgen Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table AbbVie Biologics and Biosimilars Basic Information List
Table AbbVie Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure AbbVie Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure AbbVie Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure AbbVie Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Sanofi Biologics and Biosimilars Basic Information List
Table Sanofi Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Sanofi Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Sanofi Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Sanofi Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Johnson & Johnson Biologics and Biosimilars Basic Information List
Table Johnson & Johnson Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Johnson & Johnson Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Novo Nordisk Biologics and Biosimilars Basic Information List
Table Novo Nordisk Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Novo Nordisk Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Novartis Biologics and Biosimilars Basic Information List
Table Novartis Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Novartis Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Novartis Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Novartis Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Merck Biologics and Biosimilars Basic Information List
Table Merck Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Merck Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Merck Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Merck Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table Lilly Biologics and Biosimilars Basic Information List
Table Lilly Biologics and Biosimilars Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)
Figure Lilly Biologics and Biosimilars Sales (K MT) and Growth Rate (2012-2017)
Figure Lilly Biologics and Biosimilars Sales Market Share in EMEA (2012-2017)
Figure Lilly Biologics and Biosimilars Revenue Market Share in EMEA (2012-2017)
Table 3sbio Biologics and Biosimilars Basic Information List
Table Changchun High Tech Biologics and Biosimilars Basic Information List
Table CP Guojian Pharmacy Biologics and Biosimilars Basic Information List
Table Biotech Pharma Biologics and Biosimilars Basic Information List
Table Gelgen Biopharma Biologics and Biosimilars Basic Information List
Table Sandoz Biologics and Biosimilars Basic Information List
Table Teva Biologics and Biosimilars Basic Information List
Table Hospira Biologics and Biosimilars Basic Information List
Table Mylan Biologics and Biosimilars Basic Information List
Table 3sbio Biologics and Biosimilars Basic Information List
Table Changchun High Tech Biologics and Biosimilars Basic Information List
Table CP Guojian Pharmacy Biologics and Biosimilars Basic Information List
Table Biotech Pharma Biologics and Biosimilars Basic Information List
Table Gelgen Biopharma Biologics and Biosimilars Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Biologics and Biosimilars
Figure Manufacturing Process Analysis of Biologics and Biosimilars
Figure Biologics and Biosimilars Industrial Chain Analysis
Table Raw Materials Sources of Biologics and Biosimilars Major Manufacturers in 2016
Table Major Buyers of Biologics and Biosimilars
Table Distributors/Traders List
Figure EMEA Biologics and Biosimilars Sales (K MT) and Growth Rate Forecast (2017-2022)
Figure EMEA Biologics and Biosimilars Revenue and Growth Rate Forecast (2017-2022)
Figure EMEA Biologics and Biosimilars Price (USD/MT) and Trend Forecast (2017-2022)
Table EMEA Biologics and Biosimilars Sales (K MT) Forecast by Region (2017-2022)
Figure EMEA Biologics and Biosimilars Sales Market Share Forecast by Region (2017-2022)
Table EMEA Biologics and Biosimilars Revenue (Million USD) Forecast by Region (2017-2022)
Figure EMEA Biologics and Biosimilars Revenue Market Share Forecast by Region (2017-2022)
Table Europe Biologics and Biosimilars Sales (K MT) Forecast by Countries (2017-2022)
Figure Europe Biologics and Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Europe Biologics and Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Europe Biologics and Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table Middle East Biologics and Biosimilars Sales (K MT) Forecast by Countries (2017-2022)
Figure Middle East Biologics and Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Middle East Biologics and Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Middle East Biologics and Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table Africa Biologics and Biosimilars Sales (K MT) Forecast by Countries (2017-2022)
Figure Africa Biologics and Biosimilars Sales Market Share Forecast by Countries (2017-2022)
Table Africa Biologics and Biosimilars Revenue (Million USD) Forecast by Countries (2017-2022)
Figure Africa Biologics and Biosimilars Revenue Market Share Forecast by Countries (2017-2022)
Table EMEA Biologics and Biosimilars Sales (K MT) Forecast by Type (2017-2022)
Figure EMEA Biologics and Biosimilars Sales Market Share Forecast by Type (2017-2022)
Table EMEA Biologics and Biosimilars Sales (K MT) Forecast by Application (2017-2022)
Figure EMEA Biologics and Biosimilars Sales Market Share Forecast by Application (2017-2022)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Research Assistance Research Assistance

We will be happy to help you find what you need. Please write to us:

+1-888-236-2744

sales@qyresearchgroups.com